Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
The Oncologist|March 22, 2006
Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease disseminationLuca Arcaini, Sara Burcheri, Andrea Rossi, et al.
Hemasphere|February 20, 2020
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network StudyLucia Morello, Sara Rattotti, Laura Giordano, et al.
British Journal of Haematology|November 30, 2010
Immunogenetics features and genomic lesions in splenic marginal zone lymphomaAndrea Rinaldi, Francesco Forconi, Luca Arcaini, et al.
Blood|January 24, 2014
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphomaGiovanni Franco, Carla Guarnotta, Barbara Frossi, et al.
Haematologica|February 24, 2018
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trialRiccardo Bomben, Simone Ferrero, Tiziana D'Agaro, et al.
Hematological Oncology|August 6, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective studyFrancesco Lanza, Federica Monaco, Fabio Ciceri, et al.
British Journal of Haematology|April 25, 2022
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.
Pageof 25